DEUTSCHE BANK AG\ - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$183,000
-28.2%
24,030
-4.1%
0.00%
Q4 2021$255,000
-18.0%
25,054
+8.1%
0.00%
Q3 2021$311,000
-40.8%
23,177
-3.0%
0.00%
Q2 2021$525,000
-14.5%
23,906
-6.2%
0.00%
Q1 2021$614,000
+2.3%
25,499
-23.6%
0.00%
Q4 2020$600,000
+144.9%
33,372
+57.9%
0.00%
Q3 2020$245,000
-83.4%
21,137
-65.3%
0.00%
-100.0%
Q2 2020$1,478,000
-69.1%
60,942
-86.0%
0.00%
-75.0%
Q1 2020$4,783,000
+1278.4%
434,001
+3196.1%
0.00%
Q4 2019$347,000
+47.0%
13,167
+26.6%
0.00%
Q3 2019$236,000
-43.9%
10,399
-24.5%
0.00%
Q2 2019$421,000
-86.1%
13,776
-92.4%
0.00%
-100.0%
Q1 2019$3,023,000
+231.8%
182,235
+282.7%
0.00%
+100.0%
Q4 2018$911,000
-85.3%
47,617
-59.8%
0.00%
-50.0%
Q3 2018$6,198,000
+65.0%
118,560
+37.1%
0.00%
+100.0%
Q2 2018$3,756,000
+187.2%
86,450
+144.6%
0.00%0.0%
Q1 2018$1,308,000
+244.2%
35,348
+84.0%
0.00%
Q4 2017$380,000
+117.1%
19,208
+171.6%
0.00%
Q3 2017$175,0007,0720.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders